Skip to main navigation
Skip to search
Skip to main content
Hong Kong Baptist University Home
Help & FAQ
Link opens in a new tab
Search content at Hong Kong Baptist University
Home
Scholars
Departments / Units
Research Output
Projects / Grants
Prizes / Awards
Activities
Press/Media
Student theses
Datasets
The microbial metabolome in metabolic-associated fatty liver disease
Mengci Li
, Cynthia Rajani
, Xiaojiao Zheng
, Wei Jia
*
*
Corresponding author for this work
Chinese Medicine - Teaching and Research Division
School of Chinese Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
11
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The microbial metabolome in metabolic-associated fatty liver disease'. Together they form a unique fingerprint.
Sort by:
Weight
Alphabetically
Keyphrases
Metabolomics
100%
Metabolic-associated Fatty Liver Disease (MAFLD)
100%
Risk Factors
28%
Insulin Resistance
14%
Obesity
14%
Inflammation
14%
Liver
14%
Diabetes
14%
Hepatocellular Carcinoma
14%
Gut Microbiota
14%
Disease-related
14%
Morbidly Obese Patients
14%
Nonalcoholic Steatohepatitis
14%
Metabolic Dysfunction
14%
Diabetic
14%
Gut Dysbiosis
14%
Increasing Age
14%
Metabolic Syndrome
14%
Potential Treatments
14%
Gut Microbial Community
14%
Male Gender
14%
Alcohol Consumption
14%
Cirrhosis
14%
Liver Failure
14%
Balloon
14%
Hepatic Manifestations
14%
Medicine and Dentistry
Metabolome
100%
Fatty Liver
100%
Non-Alcoholic Fatty Liver Disease
100%
Gut
33%
Hyperlipidemia
33%
Diabetes
16%
Gut Microbiota
16%
Hepatocellular Carcinoma
16%
Diabetes Mellitus
16%
Nonalcoholic Fatty Liver
16%
Dysbiosis
16%
Insulin Resistance
16%
Metabolic Syndrome
16%
Alcohol Consumption
16%
Liver Cirrhosis
16%
Liver Failure
16%
Immunology and Microbiology
Metabolome
100%
Intestine Flora
50%
Insulin Resistance
50%
Steatohepatitis
50%
Dysbiosis
50%
Pharmacology, Toxicology and Pharmaceutical Science
Fatty Liver
100%
Hyperlipidemia
28%
Insulin Resistance
14%
Inflammation
14%
Intestine Flora
14%
Diabetes Mellitus
14%
Nonalcoholic Fatty Liver
14%
Liver Cell Carcinoma
14%
Dysbiosis
14%
Metabolic Syndrome X
14%
Liver Cirrhosis
14%
Liver Failure
14%